维普中文期刊产品整合服务

Synthesis and antitumor activities of a new series of 4,5-dihydro-1H-thiochromeno[4,3-d]pyrimidine derivatives

查看全文 作  者:GUO [1]DeXiang;LIU [1]YaJing;LI [1]Ting;WANG [1]Nan;ZHAI [1]Xin;HU [1]Chun;GONG [1]Ping 高影响力作者 机构地区:[1]Key Laboratory of New Drugs Design and Discovery of Liaoning Province,School of Pharmaceutical Engineering,Shenyang Pharmaceutical University,Shenyang 110016,China高影响力机构 出  处:《Science China Chemistry》索引2012年第55卷第3期,共5页高影响力期刊 基  金:supported by the National Natural Science Foundation of China (20474053) 摘  要:A new series of 4,5-dihydro-1H-thiochromeno[4,3-d]pyrimidine derivatives have been designed and synthesized.The antitumor activities of the target compounds have been evaluated in vitro against two human cancer cell lines including A549 (human alveolar adenocarcinoma cell) and H460 (human lung cancer) by MTT assay.Most of the target compounds exhibited significant antitumor activities against A549 and H460 cancer cell lines.The most potent compound 4-(benzo[d][1,3]dioxol5-yl)-8,9-difluoro-2-(4-methylpiperazin-1-yl)-4,5-dihydro-1H-thiochromeno[4,3-d]pyrimidine (CH05) (IC50=0.44 M,3.07 M) was 2.0 and 8.4 times more active than gefitinib (IC50=0.89 M,16.81 M) against A549 and H460 cell lines,respectively. 关 键 词:抗肿瘤活性 嘧啶衍生物 二氢 合成 肿瘤细胞株 A549细胞 IC50 化合物
相关文献

参考文献(14)

引证文献(2)

耦合文献(11)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费